AstraZeneca invests in antisense therapies
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 03 Aug, 2015
Singapore: Isis Pharmaceuticals and AstraZeneca have made a strategic collaboration to discover and develop antisense th...Read more
NIH launches clinical trial focused on HIV-related CV disease
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 16 Apr, 2015
Singapore: Researchers have begun enrolling participants in to a multicenter international clinical trial to test whethe...Read more
Biogen inks autoimmune deal with Mitsubhishi Tanabe pharma
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 11 Sep, 2015
Singapore: US-based Biogen, a leading developer of therapies for neurodegenerative diseases has inked a pact with Japan'...Read more
Janssen seeks approval for drug resistant TB drug in EU
Drug Discovery | Regulatory | By BioSpectrum Bureau | 0 Comment | 04 Sep, 2012
Singapore: Janssen-Cilag International NV (Janssen) submitted a marketing authorization application to the European Medi...Read more
Thailand develops its first-ever indigenous drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 26 Dec, 2012
Singapore: Thailand's former science and technology (S&T) minister, Professor Yongyuth Yuthavong, and his team have ...Read more
J&J starts clinical trial of Ebola vaccine in Sierra Leone
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 12 Oct, 2015
Johnson & Johnson (J&J) has announced the start of a safety and immunogenicity clinical trial in Sierra Leone of...Read more
ASLAN's bile duct cancer drug receives orphan drug status
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 21 Aug, 2015
Singapore: Singapore's ASLAN pharmaceuticals recently announced that the Food and Drug Administration (FDA) has granted ...Read more
TaiGen initiates clinical trial of leukemia drug in China
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 04 May, 2015
Singapore: Taiwan's TaiGen Biotechnology has initiated first burixafor trial for relapsed or refractory acute myeloid le...Read more
China approves Bayer's Xarelto
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 05 May, 2015
Singapore: Bayer's anticoagulant drug, Xarelto (rivaroxaban), has been approved by the China Food and Drug Administratio...Read more
ScinoPharm, Foresee form joint venture
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 01 Feb, 2013
Singapore: Taiwanese company ScinoPharm and US-based Foresee Pharmaceuticals have signed an investment agreement to form...Read more
Novogen's drug shows positive result for brain cancer
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 05 Mar, 2015
Singapore: Australian biotechnology company, Novogen's lead candidate product, TRXE-009, has shown a positive result in ...Read more
Phosphagenics achieves biggest milestone yet
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 29 Oct, 2013
Singapore: Australian drug delivery technology company, Phosphagenics has achieved succes in its multi-dose oxymorphone ...Read more
Aussie firm trials combination therapy for melanoma
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 29 Sep, 2015
Singapore: Australia based Viralytics has initiated a clinical trial to assess its oncolytic virus, Cavatak, in combinat...Read more
Aussie chemotherapy drug gets orphan designation
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 23 Apr, 2015
Singappore: US Food and Drug Administration (FDA) has granted orphan drug designation to chemotherapy drug candidate Can...Read more
Eisai submits Lenvatinib's new application in Europe
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 13 Jan, 2016
Tokyo: Japan's pharma giant Eisai Co Ltd announced that its European regional headquarters Eisai Europe Ltd has submitte...Read more
Baxter expands oncology pipeline through acquisition
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 13 May, 2015
Singapore: Baxter has acquired Oncaspar (pegaspargase) product portfolio, a first-line biologic used as part of a multi-...Read more
Prana completes phase II trial with PBT2
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Jul, 2013
Singapore: Prana Biotechnology announced the successful completion of Reach2HD, a phase II clinical trial in patients wi...Read more
Clue to future universal dengue vaccine found
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 14 Aug, 2013
Singapore: Scientists at A*Star's Singapore Immunology Network (SIgN) have discovered a clue that has the potential to c...Read more